 |
dendritic cells pulsed with synthetic peptides derived from antigens MAGE1, HER-2, AIM-2,TRP-2, gp100 and interleukin-13 receptor alpha |
|---|---|
| Trade Name | |
| Orphan Indication | Glioblastoma |
| USA Market Approval | USA |
| USA Designation Date | 2010-06-07 00:00:00 |
| Sponsor | ImmunoCellular Therapeutics Ltd.;21900 Burbank Blvd;Woodland Hills, California, 91367 |
